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Abstract A radio-ribonuclease inhibitor assay based on the
interaction of 125I-angiogenin with ribonuclease inhibitor (RI)
was used to detect pancreatic-type ribonucleases and potential
modulators of their action. We show that highly basic proteins
including the homopolypeptides poly-arginine, poly-lysine and
poly-ornithine, core histones, spermatid-specific S1 protein and
the protamines HP3 and Z3 were strong inhibitors of angiogenin
binding to RI. A minimum size of poly-arginine and poly-lysine
was required for efficient inhibition. The inhibition likely resulted
from direct association of the basic proteins with the acidic
inhibitor, as RI bound to poly-lysine and protamines while 125I-
angiogenin did not. Antagonists of the angiogenin-RI interaction
are potential regulators of either angiogenin-triggered angiogen-
esis and/or intracellular RI function, depending on their
preferential target.
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1. Introduction
The RNase superfamily consists of low molecular weight
proteins structurally related to RNase A [1,2]. Several of these
RNases are inhibited in vitro by a unique 51 kDa polypeptide
known as the RNase inhibitor (RI). This is the case for pan-
creatic RNase [3,4], angiogenin [3], eosinophil-derived neuro-
toxin (EDN; also referred as to liver or placental RNase)
[5,6], eosinophil cationic protein (ECP) [7], tumor RNase
[8], bovine seminal ribonuclease (BS-RNase) monomers [9]
and mammalian orthologous RNases [10,11]. The inhibitor
binds tightly at a ratio of one to one with RNases [10,11].
Its crystal analysis has shown a horseshoe shape. In this con-
formation, the inhibitor binds to an extensive surface of
RNase A and angiogenin that includes part of their substrate
binding sites [12,13].
On the basis of the angiogenin interaction with RI, an in
vitro binding assay has been developed to detect members of
the RNase superfamily whatever their catalytic activities [14].
Using this assay, we now report that basic homopolyamino
acids as well as the lysine- and/or arginine-rich proteins his-
tones and protamines, although structurally unrelated to
RNases, are potent competitors of angiogenin binding to
RI. Like poly(Lys) and protamines, these competitors prob-
ably exert their e¡ect by direct binding to the inhibitor. These
results indicate that basic RNA or DNA binding proteins
represent potential physiological inhibitors of RI and there-
fore local regulators of RNase functions.
2. Materials and methods
2.1. Materials
Human recombinant angiogenin was from RhoŒne-Poulenc Rorer
([Met31] angiogenin) or R. Shapiro ([6Glu1] angiogenin). Bovine
RNase A was from Calbiochem (San Diego, CA, USA). Protein con-
centration was determined by spectrophotometric absorption at 280
nm for angiogenin (O= 12 500 M31 cm31) and at 278 nm for RNase A
(O= 9800 M31 cm31) [5,15]. Restrictocin was from J. Davies. EDN
and ECP were a gift from G. Gleich and BS-RNase was from G.
D’Alessio. Native human RI was either supplied from Pharmacia
(Uppsala, Sweden) or puri¢ed from erythrocytes [16], the two protein
inhibitors giving essentially similar results. The activity of RI is re-
ported in units (U), one unit being the amount required to inhibit 50%
of 5 ng of RNase A in an assay using wheat germ RNA [16]. Prot-
amine Z3 and spermatid-speci¢c protein S1, both from dog¢sh, and
alkylated human protamine HP3 were obtained according to reported
procedures [17^19]. Calf thymus crude histone fractions were prepared
according to the methods described by Johns [20,21]. Histones H2A,
H2B, H3 and H4 were further puri¢ed by gel ¢ltration on Biogel P60
(H2A, H2B) or Biogel P10 (H3, H4). Protamine and histone concen-
trations were determined by the Bio-Rad protein assay using BSA as
standard. Poly(Lys) (4^15 kDa)-agarose, protamine-agarose, para-hy-
droxymercurybenzoate (p-HMB), bovine serum albumin (BSA), re-
combinant human lysozyme, arginine, lysine, putrescine, spermidine,
spermine and homopoly-L-amino acids were from Sigma Chemical
Co. (St Louis, MO, USA). Protein A-agarose and hydrogen peroxide
(H2O2) were from Pierce (Rockford, IL, USA).
2.2. Radio-ribonuclease inhibitor assay (RRIA)
Angiogenin was iodinated using the chloramine-T method [22]. 125I-
Angiogenin was then loaded on a column containing 0.2 ml of hep-
arin-Sepharose (Pharmacia). After a wash with MOPS-bu¡ered saline
(MBS, 20 mM MOPS, 130 mM NaCl, 3 mM KCl, pH 7.2) containing
1 mg/ml BSA, the iodinated protein was eluted in MBS, 1 M NaCl,
1 mg/ml BSA, and desalted in MBS, 1 mg/ml BSA on a PD10 column
(Pharmacia). The speci¢c radioactivity of the labelled protein was
between 220 000 and 450 000 cpm/ng (1.5^3 Ci/Wmol). RRIA was per-
formed at 20‡C essentially as described [14]. 125I-Angiogenin (7000^
15 000 cpm) and the test samples were diluted in RRIA bu¡er (MBS,
1 mg/ml BSA, 5 mM EDTA, 0.02% NaN3 ; ¢nal volume 460 Wl).
Then, 0.015 U RI in 20 Wl MBS, 5 mM DTT, pH 7.2 was added
and incubation was continued for 10 min. 125I-AngiogenincRI com-
plexes were precipitated in 50% ammonium sulfate in the presence of
the globulin fraction of fetal calf serum [14]. Free 125I-angiogenin was
measured by counting aliquots of the supernatants. The data were
analyzed using the RIA program operated by a 1275 MiniGamma
counter (LKB). Experiments were performed at least twice in dupli-
cate or triplicate.
2.3. Binding of RI to poly(Lys) and protamines
The interaction of RI with poly(Lys) and protamines was studied
by incubating 0.12 U of RI in the presence of a given amount of
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poly(Lys) or protamines coupled to beaded agarose. The reaction was
run in polypropylene tubes for 15 min at 20‡C in 200 Wl of RRIA
bu¡er, 5 mM DTT. The tubes were centrifuged and 50 Wl aliquots of
supernatant were incubated with 10 000 cpm 125I-angiogenin for 10
min. RI was then quanti¢ed using the RRIA procedure described
above. RI bound to protein-agarose was released after two washes
in RRIA bu¡er, 5 mM DTT and incubation for 15 min in the same
bu¡er containing 2 M NaCl. 125I-Angiogenin did not signi¢cantly
bind to poly(Lys)-agarose or protamine-agarose in RRIA bu¡er. Con-
trol experiments were carried out using protein A coupled to agarose.
3. Results
3.1. Radio-ribonuclease inhibitor assay
125I-Angiogenin binding to RI was quanti¢ed using di¡er-
ential precipitation of bound vs. free 125I-angiogenin at 50%
ammonium sulfate saturation. In the absence of RI, 90^95%
of the radioactivity was recovered in the soluble fraction. In
the presence of RI, 125I-angiogenin precipitation increased
with the RI/angiogenin ratio. Approximately 50% precipita-
tion of the tracer was induced by 0.015 U RI, maximum
activity being obtained with V0.03 U RI (Fig. 1A). Thus,
the RI/angiogenin ratio used in this assay was nearly identical
to the RI/RNase A ratio required for enzymatic inhibition in
ribonucleolytic assays [16]. The thiol reagent p-HMB abol-
ished this e¡ect, in keeping with its ability to inactivate RI
in ribonucleolytic assays [23] and to dissociate RIcangiogenin
complexes [24]. Likewise, H2O2 interfered with the formation
of 125I-angiogenincRI complexes (Fig. 1B). However, the pres-
ence of DTT (0.2 mM) and BSA (which probably acted here
as a radical scavenger) strongly limited the e¡ect of H2O2 as a
large amount of the oxidant was required for inhibition. Other
thiol compounds (L-cysteine and glutathione) also protected
RI from H2O2-mediated oxidation (not shown).
3.2. RRIA detects RNases of the pancreatic RNase superfamily
RRIA was performed using the RI concentration required
to bind 50^70% of the angiogenin tracer. The speci¢city of the
assay was assessed by adding angiogenin-related RNases as
potential competitors. As expected, 125I-angiogenincRI com-
plex formation was gradually inhibited in the presence of in-
creasing amounts of unlabeled angiogenin. 10 pmol of [Met31]
angiogenin (Fig. 2) or [6Glu1] angiogenin (not shown) was
detected, the inhibitory concentration (IC50) of both mole-
cules being 140 pM. Other RNases related to angiogenin com-
peted strongly for the binding of 125I-angiogenin to RI. The
most potent antagonist (apart from angiogenin itself) was
RNase A (IC50 of 120 pM), in keeping with the ability of
RI to inhibit the catalytic activity of the enzyme [3,4]. IC50
values for angiogenin and RNase A did not di¡er signi¢-
cantly. The neurotoxin EDN, whose ribonucleolytic [5,6]
and biological [25] activities are inhibited by RI, prevented
125I-angiogenin binding with an IC50 of 0.7 nM. The behavior
of the closely related protein ECP was similar. Finally, BS-
RNase was also a potent competitor (IC50V1.3 nM). Con-
versely, angiogenin inactivated by reduction and alkylation,
the basic protein lysozyme and the unrelated RNase restricto-
cin failed to compete at concentrations of 60^75 nM. The
speci¢c binding of basic RNases (pIs 9) to RI (pIV4.7)
was thus not solely determined by ionic interactions and re-
quired an ordered three-dimensional conformation of the
RNases [12,13].
The IC50 values thus depend on the RNase and probably
re£ect di¡erences in association rates (k2/K1) rather than as-
sociation constants (Ka), as the assays were not performed in
conditions of equilibrium (owing to the instability of the in-
hibitor relative to the extremely low dissociation rate of
RNase RIccomplexes) [3,4]. Other factors such as polymeriza-
tion of RNase subunits may contribute to IC50 variations, as
illustrated here by the moderate e¡ect of BS-RNase. In fact,
competition with BS-RNase was unexpected as the native di-
meric form of the enzyme is not inhibited by RI. This obser-
vation probably resulted from the existence of BS-RNase
monomers generated by the presence of DTT in the reaction
mixture [9].
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Fig. 1. E¡ect of p-HMB and H2O2 on the binding of 125I-angioge-
nin to RI. 125I-Angiogenin (25 pg, 10 000 cpm) was incubated with
RI for 10 min at 20‡C in the standard assay mixture. Separation of
bound and free ligand was carried out in 50% saturated ammonium
sulfate, and free 125I-angiogenin was quanti¢ed by determining the
percentage of total radioactivity present in the supernatant. A: The
assay was performed in the presence of increasing amounts of RI,
in the presence (E) or absence (F) of 1 mM p-HMB. B: A similar
experiment was performed in the presence (b) or absence (a) of
0.03 U RI with increasing amounts of H2O2 (a 1% hydrogen perox-
ide solution corresponds to 376 mM H2O2). Each result is the mean
of duplicate determinations that di¡ered by less than 5%.
Fig. 2. Competitive binding RRIA. Competition for 125I-angiogenin
binding to 0.015 U RI by (F) [Met31] angiogenin, (E) RNase A,
(O) EDN, (R) ECP, (8) BS-RNase, (b) alkylated angiogenin; (a)
restrictocin and (+) human lysozyme. The results are expressed as
the percentage of a control in which half the 125I-angiogenin bound
to RI. Values are the means of duplicate determinations that dif-
fered by less than 5%. The experiment was repeated three times
with similar results. The expression of the protein concentrations is
based on the following molecular masses (in Da): angiogenin,
14 100; RNase A, 13 700; EDN, 15 460; ECP, 15 570; BS-RNase,
27 200; lysozyme, 14 000; restrictocin, 16 840.
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3.3. Basic homopolyamino acids, histones and protamines
inhibited 125I-angiogenin binding to RI
Several lysine/arginine residues of RNase A contribute to its
binding to RI. Although most of these basic residues are in
unconserved positions in other RI-interacting RNases, they
play a key role in the binding of angiogenin (and perhaps
EDN) to the inhibitor [12,13,26]. This suggests that other
basic polypeptides could interfere with RI and act as compet-
itors for RNase binding. Indeed, poly(Arg), poly(Lys) and
poly(Orn) inhibited 125I-angiogenin binding to RI, with IC50
values in the 4^300 nM range (Fig. 3A). In contrast, no com-
petition was observed with poly(Asn), which suggests that the
cationic charge was a determining factor for e¡ective inhib-
ition. Because the polyamines putrescine, spermidine and
spermine did not interfere to a measurable extent in the assay
(not shown), the in£uence of cationic homopolymers was also
assessed as a function of their size. As shown in Fig. 3B, the
size of both poly(Arg) and poly(Lys) correlated with their
ability to compete, the most potent e¡ects being observed
with the largest polymers. The 92 kDa poly(Arg) (IC50V
1 M) was almost as potent as ECP and EDN (IC50V0.7
nM) and only seven-fold less active than angiogenin and
RNase A (V0.14 nM). IC50 values were also in the nM range
with lysine polymers of high molecular mass, although
poly(Lys) was less active than poly(Arg). In comparison, ar-
ginine, lysine and the lysine pentamer did not compete signi¢-
cantly, and the lysine heptamer gave an IC50 value of 100 WM.
We then considered the possibility that natural lysine- and/
or arginine-rich proteins have similar properties by testing
histones, protamines and the spermatid-speci¢c S1 protein.
As shown in Table 1, the results were consistent with those
observed with poly(Arg) and poly(Lys): the higher the basic
amino acid content, the stronger the competitive e¡ect. The
strong activity of H3, compared with H4, might be related to
its higher arginine content. Finally, the protein Z3 was a less
potent inhibitor than the protamine HP3; although Z3 is even
closer to the poly(Arg) structure (65% arginine residues vs.
52%), its shorter size could be a limiting factor for inhibition
(see Fig. 3B).
3.4. Association of RI with poly(Lys) and protamines
The activity of basic homopolymers, histones and prot-
amines probably resulted from their direct interaction with
RI, as the inhibitor bound to either poly(Lys) or protamines
coupled to agarose beads (Fig. 4) while 125I-angiogenin did
not (not shown). The binding was somewhat speci¢c as pro-
tein A-agarose did not retain RI. Binding was also reversible
as RI dissociated from the insolubilized proteins at higher salt
concentrations. These results suggest that the activity of
highly basic polypeptides is determined by their ability to




E¡ect of histones and protamines on the binding of 125I-angiogenin to RI
Protein IC50 (WM) Total number of residues per mol Basic residues (%) Ref.
Arg Lys Arg+Lys
H2A 2.90 129 9.3 10.9 20.2 [31]
H2B 0.69 125 6.4 16.0 22.4 [32]
H3 0.70 135 13.3 9.6 23.0 [33]
H4 1.00 102 10.8 13.7 24.5 [34]
S1 0.59 87 35.6 9.2 44.8 [19]
HP3 0.25 54 48.1 3.7 51.8 [35]
Z3 0.37 37 64.8 0 64.8 [36]
RRIA was performed as described in Section 2. Proteins are listed according to their basic residue contents (%). The molecular masses of the
proteins (in Da) were: H2A, 13 962; H2B, 13 777; H3, 15 257; H4, 11 238; S1, 11 179; HP3, 7260 and Z3, 4748. Values for IC50 are the means of
duplicate determinations that di¡ered by less than 5%.
Fig. 3. E¡ect of homopolyamino acids on the interaction of 125I-an-
giogenin with RI. Competition for binding of 125I-angiogenin to RI
by various synthetic polyamino acids. A: E¡ect of di¡erent homo-
polyamino acids. (F) Poly(Arg) (12.1 kDa); (E) poly(Lys) (9.6
kDa); (b) poly(Orn) (7.6 kDa); (a) poly(Asn) (10.4 kDa). B: Size
e¡ect of arginine and lysine polymers on the binding of 125I-angio-
genin to RI. Arginine, lysine and the following polymers were
studied: poly(Arg): 12.1, 45.5 and 92.0 kDa; poly(Lys): 0.665, 1.0,
9.6 and 42.0 kDa. IC50 values were assimilated to the r value for
compounds whose competitive e¡ect was below 50% at 100 WM.
Values are the means of duplicate determinations that di¡ered by
less than 5%.
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4. Discussion
The mammalian RNase superfamily consists of related en-
zymes whose archetype is RNase A [1,2]. These RNases share
common structural determinants, have conserved catalytic
amino acid residues, and are thought to have evolved from
a single ancestral gene [1]. Their catalytic properties di¡er in
terms of kinetic constants and substrate speci¢cities; several
of these RNases, including pancreatic RNase, EDN, BS-
RNase and tumor RNase, are potent enzymes while others,
exempli¢ed by angiogenin and ECP, have extremely low ribo-
nucleolytic activity in conventional assays and were discov-
ered through their biological properties (reviewed in [2]).
RI, a cytosolic protein, inhibits a number of these RNases
with one to one stoichiometry [10,11]. Using a radio-ribonu-
clease inhibitor assay that detects interacting RNases, we fo-
cused on potential antagonists of angiogenin binding to RI.
We observed that basic homopolypeptides interfered with this
binding, the most potent inhibitor being poly(Arg). The in-
hibition mediated by homopolypeptides was likely dependent
on their ionic charge as poly(Asn) had no e¡ect. It was also
relative to their size as arginine, lysine and lysine oligomers
had no signi¢cant activity while higher molecular weight poly-
mers were fully active. Similarly, several histones and prot-
amines were potent inhibitors of angiogenin binding to RI. As
poly(Lys) and protamines were shown to interact directly with
RI, we suggest that the other basic competitors act similarly,
therefore preventing angiogenin binding by steric hindrance.
The e¡ect of highly basic proteins may be related to the pres-
ence of ¢ve lysine and one arginine residues in RNase A (Lys-
7, Lys-31, Lys-41, Lys-66, Lys-91 and Arg-39) that are in-
volved in its binding to RI [12]. As regards angiogenin, apart
from the involvement of Lys-40, six arginine residues (Arg-5,
Arg-24, Arg-31, Arg-32, Arg-95 and Arg-121) substantially
contribute to RI binding [13]. The strong involvement of basic
residues in the binding of angiogenin to the inhibitor might be
mimicked in part by basic homopolyamino acids, histones and
protamines.
The biological function of RI is unknown. Present hypoth-
eses addressing this question are based on its high potency to
inhibit RNases and suggest a regulatory and/or protective role
of RI [11]. However, the physiological relevance of such in-
teractions has not yet been proved, a major concern being
that the inhibitor is an intracellular protein whereas RNases
are secreted. The possibility that RI be endowed with distinct
functions cannot be excluded as well. The striking sensitivity
of RI to oxidative stresses in nucleated cells and erythrocytes
[16,27] raises additional questions as to its role and metabo-
lism. Research on the possible occurrence of RNase/angioge-
nin in intracellular compartments [28], associated with a better
knowledge of the subcellular location of RI, will be necessary
to approach these questions and those related to the signi¢-
cance of the binding of RI to highly basic proteins. Studies on
the biological properties of RI should also be facilitated by
the design of speci¢c inhibitors. The extreme potency of poly-
(Arg) makes RI a preferential target in vivo, as higher con-
centrations of the synthetic peptide are usually required for
modulation of other protein functions [29,30]. Starting from
the basic structure of poly(Arg), heteropolyamino acids with
tighter binding to RI could be synthesised, therefore opening
new possibilities for such investigations.
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